AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. SER
  4. [Form 4] Serina Therapeutics, Inc. Insider Trading Activity

[Form 4] Serina Therapeutics, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Filing content is currently unavailable.

Source:

Stock SER logo
Serina Therapeutics

NYSE:SER

SER Rankings

#5169 Ranked by Market Cap
N/A Ranked by Dividends
#5 Top Gainer

SER Latest News

Aug 25, 2025
Serina Therapeutics Announces FDA Feedback Supports Registrational Trial Design of SER-252 in Advanced Parkinson’s Disease under 505(b)(2) NDA Pathway
Aug 11, 2025
Serina Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights
Jul 29, 2025
Serina Therapeutics Advances POZ-VMAT2i into Development for Tardive Dyskinesia (TD)
Jul 28, 2025
Serina Therapeutics to Present at the BTIG Virtual Biotechnology Conference
Jul 10, 2025
Serina Therapeutics Makes Grant to New Employee Under Inducement Plan

SER Latest SEC Filings

Aug 25, 2025
[8-K] Serina Therapeutics, Inc. Reports Material Event
Aug 22, 2025
[8-K] Serina Therapeutics, Inc. Reports Material Event
Aug 20, 2025
[Form 4] Serina Therapeutics, Inc. Insider Trading Activity
Aug 11, 2025
[8-K] Serina Therapeutics, Inc. Reports Material Event
Aug 6, 2025
[Form 4] Serina Therapeutics, Inc. Insider Trading Activity

SER Stock Data

57.92M
3.89M
62.09%
4.03%
0.51%
Biotechnology
Pharmaceutical Preparations
United States
HUNTSVILLE